{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:55:36Z","timestamp":1765961736334,"version":"3.37.3"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10787-023-01394-8","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T16:02:16Z","timestamp":1703088136000},"page":"319-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mesenchymal stem cell therapy for COVID-19 infection"],"prefix":"10.1007","volume":"32","author":[{"given":"Seyyed Mohammad Matin","family":"Alavi-Dana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazdan","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Meghdadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Saleh","family":"Fadaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9268-6270","authenticated-orcid":false,"given":"Vahid Reza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"1394_CR1","doi-asserted-by":"publisher","first-page":"963689721102494","DOI":"10.1177\/09636897211024942","volume":"30","author":"G Adas","year":"2021","unstructured":"Adas G, Cukurova Z, Yasar KK, Yilmaz R, Isiksacan N, Kasapoglu P, Yesilbag Z, Koyuncu ID, Karaoz E (2021) The systematic effect of mesenchymal stem cell therapy in critical COVID-19 patients: a prospective double controlled trial. Cell Transplant 30:9636897211024942. https:\/\/doi.org\/10.1177\/09636897211024942","journal-title":"Cell Transplant"},{"issue":"1","key":"1394_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-022-02953-6","volume":"13","author":"HR Aghayan","year":"2022","unstructured":"Aghayan HR, Salimian F, Abedini A, Fattah Ghazi S, Yunesian M, Alavi-Moghadam S, Makarem J, Majidzadeh-A K, Hatamkhani A, Moghri M (2022) Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment. Stem Cell Res Ther 13(1):1\u201312","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"1394_CR3","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.rmed.2010.04.015","volume":"104","author":"KM Antoniou","year":"2010","unstructured":"Antoniou KM, Papadaki HA, Soufla G, Kastrinaki MC, Damianaki A, Koutala H, Spandidos DA, Siafakas NM (2010) Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in idiopathic pulmonary fibrosis (IPF). Respir Med 104(10):1535\u20131542","journal-title":"Respir Med"},{"key":"1394_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.737590","volume":"8","author":"E Arabpour","year":"2021","unstructured":"Arabpour E, Khoshdel S, Tabatabaie N, Akhgarzad A, Zangiabadian M, Nasiri MJ (2021) Stem cells therapy for COVID-19: a systematic review and meta-analysis. Front Med 8:737590","journal-title":"Front Med"},{"issue":"3","key":"1394_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4252\/wjsc.v6.i3.256","volume":"6","author":"PC Baer","year":"2014","unstructured":"Baer PC (2014) Adipose-derived mesenchymal stromal\/stem cells: an update on their phenotype in vivo and in vitro. World J Stem Cells 6(3):256","journal-title":"World J Stem Cells"},{"key":"1394_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/812693","volume":"2012","author":"PC Baer","year":"2012","unstructured":"Baer PC, Geiger H (2012) Adipose-derived mesenchymal stromal\/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int 2012:1\u201311","journal-title":"Stem Cells Int"},{"issue":"3","key":"1394_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/rheumatology\/kel267","volume":"46","author":"C Bocelli-Tyndall","year":"2007","unstructured":"Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, Pistoia V, Martin I, Tyndall A (2007) Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous-and allogeneic-stimulated lymphocytes in vitro. Rheumatology 46(3):403\u2013408","journal-title":"Rheumatology"},{"issue":"1","key":"1394_CR8","doi-asserted-by":"publisher","first-page":"28250","DOI":"10.1038\/srep28250","volume":"6","author":"M Cai","year":"2016","unstructured":"Cai M, Shen R, Song L, Lu M, Wang J, Zhao S, Tang Y, Meng X, Li Z, He Z-X (2016) Bone marrow mesenchymal stem cells (BM-MSCs) improve heart function in swine myocardial infarction model through paracrine effects. Sci Rep 6(1):28250","journal-title":"Sci Rep"},{"issue":"27","key":"1394_CR9","doi-asserted-by":"publisher","first-page":"9714","DOI":"10.12998\/wjcc.v10.i27.9714","volume":"10","author":"JX Cao","year":"2022","unstructured":"Cao JX, You J, Wu LH, Luo K, Wang ZX (2022) Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review. World J Clin Cases 10(27):9714\u20139726. https:\/\/doi.org\/10.12998\/wjcc.v10.i27.9714","journal-title":"World J Clin Cases"},{"key":"1394_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.07.001","author":"C-Y Chen","year":"2022","unstructured":"Chen C-Y, Chen W-C, Hsu C-K, Chao C-M, Lai C-C (2022) The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. J Infect Public Health. https:\/\/doi.org\/10.1016\/j.jiph.2022.07.001","journal-title":"J Infect Public Health"},{"issue":"6","key":"1394_CR11","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1007\/s12015-022-10398-w","volume":"18","author":"M Chu","year":"2022","unstructured":"Chu M, Wang H, Bian L, Huang J, Wu D, Zhang R, Fei F, Chen Y, Xia J (2022) Nebulization therapy with umbilical cord mesenchymal stem cell-derived exosomes for COVID-19 pneumonia. Stem Cell Rev Rep 18(6):2152\u20132163","journal-title":"Stem Cell Rev Rep"},{"key":"1394_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.631463","volume":"12","author":"E De Klerk","year":"2021","unstructured":"De Klerk E, Hebrok M (2021) Stem cell-based clinical trials for diabetes mellitus. Front Endocrinol 12:631463","journal-title":"Front Endocrinol"},{"issue":"9","key":"1394_CR13","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/sctm.21-0046","volume":"10","author":"IH Dilogo","year":"2021","unstructured":"Dilogo IH, Aditianingsih D, Sugiarto A, Burhan E, Damayanti T, Sitompul PA, Mariana N, Antarianto RD, Liem IK, Kispa T (2021) Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: a randomized controlled trial. Stem Cells Transl Med 10(9):1279\u20131287","journal-title":"Stem Cells Transl Med"},{"key":"1394_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt75","volume":"2","author":"MM Duffy","year":"2011","unstructured":"Duffy MM, Ritter T, Ceredig R, Griffin MD (2011) Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther 2:1\u20139","journal-title":"Stem Cell Res Ther"},{"key":"1394_CR15","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s12015-021-10214-x","volume":"17","author":"ON Ercelen","year":"2021","unstructured":"Ercelen ON, Pekkoc-Uyanik KC, Alpaydin N, Gulay GR, Simsek M (2021) Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey. Stem Cell Rev Rep 17:1917\u20131925","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"1394_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13287-022-02771-w","volume":"13","author":"M Fathi-Kazerooni","year":"2022","unstructured":"Fathi-Kazerooni M, Fattah-Ghazi S, Darzi M, Makarem J, Nasiri R, Salahshour F, Dehghan-Manshadi SA, Kazemnejad S (2022) Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II. Stem Cell Res Ther 13(1):96","journal-title":"Stem Cell Res Ther"},{"issue":"01","key":"1394_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/ard.2008.101881","volume":"69","author":"E Gonzalez-Rey","year":"2010","unstructured":"Gonzalez-Rey E, Gonzalez MA, Varela N, O\u2019Valle F, Hernandez-Cortes P, Rico L, B\u00fcscher D, Delgado M (2010) Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 69(01):241\u2013248","journal-title":"Ann Rheum Dis"},{"key":"1394_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932360","volume":"13","author":"C Gr\u00e9goire","year":"2022","unstructured":"Gr\u00e9goire C, Layios N, Lambermont B, Lechanteur C, Briquet A, Bettonville V, Baudoux E, Thys M, Dardenne N, Misset B, Beguin Y (2022) Bone marrow-derived mesenchymal stromal cell therapy in severe COVID-19: preliminary results of a phase I\/II clinical trial. Front Immunol 13:932360. https:\/\/doi.org\/10.3389\/fimmu.2022.932360","journal-title":"Front Immunol"},{"issue":"1","key":"1394_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02165-4","volume":"12","author":"S-MR Hashemian","year":"2021","unstructured":"Hashemian S-MR, Aliannejad R, Zarrabi M, Soleimani M, Vosough M, Hosseini S-E, Hossieni H, Keshel SH, Naderpour Z, Hajizadeh-Saffar E (2021) Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series. Stem Cell Res Ther 12(1):1\u201312","journal-title":"Stem Cell Res Ther"},{"key":"1394_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/9346939","volume":"2022","author":"A Javed","year":"2022","unstructured":"Javed A, Karki S, Sami Z, Khan Z, Shree A, Sah BK, Ghosh S, Saxena S (2022) Association between mesenchymal stem cells and covid-19 therapy: systematic review and current trends. BioMed Res Int 2022:1\u201317","journal-title":"BioMed Res Int"},{"issue":"1","key":"1394_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13287-022-02920-1","volume":"13","author":"N Kaffash Farkhad","year":"2022","unstructured":"Kaffash Farkhad N, Sedaghat A, Reihani H, Adhami Moghadam A, Bagheri Moghadam A, Khadem Ghaebi N, Khodadoust MA, Ganjali R, Tafreshian AR, Tavakol-Afshari J (2022) Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial. Stem Cell Res Ther 13(1):283","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1394_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13287-022-02812-4","volume":"13","author":"M Karyana","year":"2022","unstructured":"Karyana M, Djaharuddin I, Rif\u2019ati L, Arif M, Choi MK, Angginy N, Yoon A, Han J, Josh F, Arlinda D, Narulita A, Muchtar F, Bakri RA, Irmansyah S (2022) Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial. Stem Cell Res Ther 13(1):134. https:\/\/doi.org\/10.1186\/s13287-022-02812-4","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1394_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01849-7","volume":"11","author":"M Kavianpour","year":"2020","unstructured":"Kavianpour M, Saleh M, Verdi J (2020) The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm. Stem Cell Res Ther 11(1):1\u201319","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"1394_CR24","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4252\/wjsc.v6.i5.552","volume":"6","author":"D Kyurkchiev","year":"2014","unstructured":"Kyurkchiev D, Bochev I, Ivanova-Todorova E, Mourdjeva M, Oreshkova T, Belemezova K, Kyurkchiev S (2014) Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells 6(5):552","journal-title":"World J Stem Cells"},{"issue":"5","key":"1394_CR25","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/sctm.20-0472","volume":"10","author":"G Lanzoni","year":"2021","unstructured":"Lanzoni G, Linetsky E, Correa D, Messinger Cayetano S, Alvarez RA, Kouroupis D, Alvarez Gil A, Poggioli R, Ruiz P, Marttos AC (2021) Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1\/2a, randomized controlled trial. Stem Cells Transl Med 10(5):660\u2013673","journal-title":"Stem Cells Transl Med"},{"key":"1394_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/632902","volume":"2015","author":"S Lee","year":"2015","unstructured":"Lee S, Choi E, Cha M-J, Hwang K-C (2015) Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy. Oxidat Med Cell Long 2015:1\u20139","journal-title":"Oxidat Med Cell Long"},{"issue":"1","key":"1394_CR27","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.1038\/s41598-018-25700-5","volume":"8","author":"DG Leuning","year":"2018","unstructured":"Leuning DG, Beijer NR, Du Foss\u00e9 NA, Vermeulen S, Lievers E, Van Kooten C, Rabelink TJ, Boer JD (2018) The cytokine secretion profile of mesenchymal stromal cells is determined by surface structure of the microenvironment. Sci Rep 8(1):7716","journal-title":"Sci Rep"},{"key":"1394_CR28","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00018-017-2473-5","volume":"74","author":"N Li","year":"2017","unstructured":"Li N, Hua J (2017) Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci 74:2345\u20132360","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"1394_CR29","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1517\/14712598.2015.1051528","volume":"15","author":"T Li","year":"2015","unstructured":"Li T, Xia M, Gao Y, Chen Y, Xu Y (2015) Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy. Expert Opin Biol Ther 15(9):1293\u20131306","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"1394_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3892\/etm.2021.10444","volume":"22","author":"C Li","year":"2021","unstructured":"Li C, He Q, Qian H, Liu J (2021a) Overview of the pathogenesis of COVID-19 (Review). Exp Ther Med 22(3):1011. https:\/\/doi.org\/10.3892\/etm.2021.10444","journal-title":"Exp Ther Med"},{"issue":"1","key":"1394_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100948","volume":"14","author":"C Li","year":"2021","unstructured":"Li C, Zhao H, Wang B (2021b) Mesenchymal stem\/stromal cells: developmental origin, tumorigenesis and translational cancer therapeutics. Transl Oncol 14(1):100948","journal-title":"Transl Oncol"},{"key":"1394_CR32","doi-asserted-by":"publisher","first-page":"104600","DOI":"10.1016\/j.ebiom.2023.104600","volume":"92","author":"T-T Li","year":"2023","unstructured":"Li T-T, Zhang B, Fang H, Shi M, Yao W-Q, Li Y, Zhang C, Song J, Huang L, Xu Z (2023) Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine 92:104600","journal-title":"EBioMedicine"},{"key":"1394_CR33","doi-asserted-by":"crossref","unstructured":"Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K (2019) Challenges and controversies in human mesenchymal stem cell therapy. Stem Cells Int 2019","DOI":"10.1155\/2019\/9628536"},{"key":"1394_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt216","volume":"4","author":"P Luz-Crawford","year":"2013","unstructured":"Luz-Crawford P, Kurte M, Bravo-Alegr\u00eda J, Contreras R, Nova-Lamperti E, Tejedor G, No\u00ebl D, Jorgensen C, Figueroa F, Djouad F (2013) Mesenchymal stem cells generate a CD4+ CD25+ Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther 4:1\u201312","journal-title":"Stem Cell Res Ther"},{"key":"1394_CR35","doi-asserted-by":"crossref","unstructured":"Mason RJ (2020) Pathogenesis of COVID-19 from a cell biology perspective. In: (Vol. 55): Eur Respiratory Soc.","DOI":"10.1183\/13993003.00607-2020"},{"issue":"1","key":"1394_CR36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41392-020-00286-5","volume":"5","author":"F Meng","year":"2020","unstructured":"Meng F, Xu R, Wang S, Xu Z, Zhang C, Li Y, Yang T, Shi L, Fu J, Jiang T (2020) Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct Target Ther 5(1):172","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"1394_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008762","volume":"16","author":"A Mittal","year":"2020","unstructured":"Mittal A, Manjunath K, Ranjan RK, Kaushik S, Kumar S, Verma V (2020) COVID-19 pandemic: insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2. PLoS Pathog 16(8):e1008762","journal-title":"PLoS Pathog"},{"issue":"1","key":"1394_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13054-022-03930-4","volume":"26","author":"A Monsel","year":"2022","unstructured":"Monsel A, Hauw-Berlemont C, Mebarki M, Heming N, Mayaux J, Nguekap Tchoumba O, Diehl J-L, Demoule A, Annane D, Marois C (2022) Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial. Crit Care 26(1):48","journal-title":"Crit Care"},{"issue":"2","key":"1394_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jmii.2020.03.022","volume":"54","author":"L Mousavizadeh","year":"2021","unstructured":"Mousavizadeh L, Ghasemi S (2021) Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect 54(2):159\u2013163","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"1394_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bjh.18292","volume":"199","author":"B Nachmias","year":"2022","unstructured":"Nachmias B, Zimran E, Avni B (2022) Mesenchymal stroma\/stem cells: haematologists\u2019 friend or foe? Br J Haematol 199(2):175\u2013189","journal-title":"Br J Haematol"},{"issue":"7","key":"1394_CR41","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/stcltm\/szac032","volume":"11","author":"W Qu","year":"2022","unstructured":"Qu W, Wang Z, Engelberg-Cook E, Yan D, Siddik AB, Bu G, Allickson JG, Kubrova E, Caplan AI, Hare JM (2022) Efficacy and safety of MSC cell therapies for hospitalized patients with COVID-19: a systematic review and meta-analysis. Stem Cells Transl Med 11(7):688\u2013703","journal-title":"Stem Cells Transl Med"},{"key":"1394_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109845","volume":"143","author":"V Rao","year":"2020","unstructured":"Rao V, Thakur S, Rao J, Arakeri G, Brennan PA, Jadhav S, Sayeed MS, Rao G (2020) Mesenchymal stem cells-bridge catalyst between innate and adaptive immunity in COVID 19. Med Hypoth 143:109845","journal-title":"Med Hypoth"},{"issue":"1","key":"1394_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-022-02796-1","volume":"13","author":"CLK Rebelatto","year":"2022","unstructured":"Rebelatto CLK, Senegaglia AC, Franck CL, Daga DR, Shigunov P, Stimamiglio MA, Marsaro DB, Schaidt B, Micosky A, de Azambuja AP, Leit\u00e3o CA, Petterle RR, Jamur VR, Vaz IM, Mallmann AP, Carraro Junior H, Ditzel E, Brofman PRS, Correa A (2022) Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial. Stem Cell Res Ther 13(1):122. https:\/\/doi.org\/10.1186\/s13287-022-02796-1","journal-title":"Stem Cell Res Ther"},{"key":"1394_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118493","volume":"262","author":"S Sadeghi","year":"2020","unstructured":"Sadeghi S, Soudi S, Shafiee A, Hashemi SM (2020) Mesenchymal stem cell therapies for COVID-19: current status and mechanism of action. Life Sci 262:118493","journal-title":"Life Sci"},{"issue":"1","key":"1394_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02483-7","volume":"12","author":"M Saleh","year":"2021","unstructured":"Saleh M, Vaezi AA, Aliannejad R, Sohrabpour AA, Kiaei SZF, Shadnoush M, Siavashi V, Aghaghazvini L, Khoundabi B, Abdoli S (2021) Cell therapy in patients with COVID-19 using Wharton\u2019s jelly mesenchymal stem cells: a phase 1 clinical trial. Stem Cell Res Ther 12(1):1\u201313","journal-title":"Stem Cell Res Ther"},{"issue":"13","key":"1394_CR46","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3390\/jcm10132991","volume":"10","author":"R Sanabria-de la Torre","year":"2021","unstructured":"Sanabria-de la Torre R, Qui\u00f1ones-Vico MI, Fern\u00e1ndez-Gonz\u00e1lez A, S\u00e1nchez-D\u00edaz M, Montero-V\u00edlchez T, Sierra-S\u00e1nchez \u00c1, Arias-Santiago S (2021) Alloreactive immune response associated to human mesenchymal stromal cells treatment: a systematic review. J Clin Med 10(13):2991","journal-title":"J Clin Med"},{"key":"1394_CR47","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Guijo F, Garc\u00eda-Arranz M, L\u00f3pez-Parra M, Monedero P, Mata-Mart\u00ednez C, Santos A, Sagredo V, \u00c1lvarez-Avello J-M, Guerrero JE, P\u00e9rez-Calvo C (2020) Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study. EClinicalMedicine 25","DOI":"10.1016\/j.eclinm.2020.100454"},{"issue":"6","key":"1394_CR48","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.arcmed.2020.05.012","volume":"51","author":"S Satarker","year":"2020","unstructured":"Satarker S, Nampoothiri M (2020) Structural proteins in severe acute respiratory syndrome coronavirus-2. Arch Med Res 51(6):482\u2013491","journal-title":"Arch Med Res"},{"issue":"12","key":"1394_CR49","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1089\/scd.2020.0080","volume":"29","author":"V Sengupta","year":"2020","unstructured":"Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N (2020) Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev 29(12):747\u2013754","journal-title":"Stem Cells Dev"},{"key":"1394_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.749192","volume":"12","author":"Z Shen","year":"2021","unstructured":"Shen Z, Huang W, Liu J, Tian J, Wang S, Rui K (2021) Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases. Front Immunol 12:749192","journal-title":"Front Immunol"},{"issue":"1","key":"1394_CR51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41392-021-00754-6","volume":"6","author":"L Shi","year":"2021","unstructured":"Shi L, Wang L, Xu R, Zhang C, Xie Y, Liu K, Li T, Hu W, Zhen C, Wang F-S (2021) Mesenchymal stem cell therapy for severe COVID-19. Signal Transduct Target Ther 6(1):339","journal-title":"Signal Transduct Target Ther"},{"key":"1394_CR52","doi-asserted-by":"publisher","first-page":"103789","DOI":"10.1016\/j.ebiom.2021.103789","volume":"75","author":"L Shi","year":"2022","unstructured":"Shi L, Yuan X, Yao W, Wang S, Zhang C, Zhang B, Song J, Huang L, Xu Z, Fu JL, Li Y, Xu R, Li TT, Dong J, Cai J, Li G, Xie Y, Shi M, Li Y, Wang FS (2022) Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine 75:103789. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103789","journal-title":"EBioMedicine"},{"issue":"1","key":"1394_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01875-5","volume":"11","author":"L Shu","year":"2020","unstructured":"Shu L, Niu C, Li R, Huang T, Wang Y, Huang M, Ji N, Zheng Y, Chen X, Shi L (2020) Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells. Stem Cell Res Ther 11(1):1\u201311","journal-title":"Stem Cell Res Ther"},{"issue":"17","key":"1394_CR54","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1089\/scd.2018.0256","volume":"28","author":"Y Wang","year":"2019","unstructured":"Wang Y, Tian M, Wang F, Heng BC, Zhou J, Cai Z, Liu H (2019) Understanding the immunological mechanisms of mesenchymal stem cells in allogeneic transplantation: from the aspect of major histocompatibility complex class I. Stem Cells Dev 28(17):1141\u20131150","journal-title":"Stem Cells Dev"},{"issue":"19","key":"1394_CR55","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1089\/scd.2021.0179","volume":"30","author":"J Wang","year":"2021","unstructured":"Wang J, Shi P, Chen D, Wang S, Wang P, Feng X, Zhang L (2021a) Research status of the safety and efficacy of mesenchymal stem cells in the treatment of COVID-19-related pneumonia: a systematic review and meta-analysis. Stem Cells Dev 30(19):947\u2013969","journal-title":"Stem Cells Dev"},{"key":"1394_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.726909","volume":"12","author":"L Wang","year":"2021","unstructured":"Wang L, Li Y, Xu M, Deng Z, Zhao Y, Yang M, Liu Y, Yuan R, Sun Y, Zhang H (2021b) Regulation of inflammatory cytokine storms by mesenchymal stem cells. Front Immunol 12:726909","journal-title":"Front Immunol"},{"issue":"2","key":"1394_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.297","volume":"11","author":"X Xu","year":"2021","unstructured":"Xu X, Jiang W, Chen L, Xu Z, Zhang Q, Zhu M, Ye P, Li H, Yu L, Zhou X (2021) Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: an exploratory clinical trial. Clin Transl Med 11(2):e297","journal-title":"Clin Transl Med"},{"key":"1394_CR58","doi-asserted-by":"publisher","first-page":"101545","DOI":"10.1016\/j.eclinm.2022.101545","volume":"51","author":"W Yao","year":"2022","unstructured":"Yao W, Dong H, Qi J, Zhang Y, Shi L (2022) Safety and efficacy of mesenchymal stem cells in severe\/critical patients with COVID-19: a systematic review and meta-analysis. EClinicalMedicine 51:101545","journal-title":"EClinicalMedicine"},{"key":"1394_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1471-y","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ding J, Ren S, Wang W, Yang Y, Li S, Meng M, Wu T, Liu D, Tian S (2020) Intravenous infusion of human umbilical cord Wharton\u2019s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia. Stem Cell Res Ther 11:1\u20136","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1394_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41256-022-00251-5","volume":"7","author":"M Zhang","year":"2022","unstructured":"Zhang M, Yan X, Shi M, Li R, Pi Z, Ren X, Wang Y, Yan S, Wang Y, Jin Y (2022) Safety and efficiency of stem cell therapy for COVID-19: a systematic review and meta-analysis. Global Health Res Policy 7(1):1\u201313","journal-title":"Global Health Res Policy"},{"issue":"1","key":"1394_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-022-02900-5","volume":"13","author":"Y-G Zhu","year":"2022","unstructured":"Zhu Y-G, Shi M-M, Monsel A, Dai C-X, Dong X, Shen H, Li S-K, Chang J, Xu C-L, Li P (2022) Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study. Stem Cell Res Ther 13(1):1\u201310","journal-title":"Stem Cell Res Ther"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01394-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01394-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01394-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T08:42:25Z","timestamp":1709368945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01394-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1394"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01394-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"22 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"No animals\/humans were used for studies that are the basis of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}